In vivo interactions between murine leukemia and sarcoma viruses

Area of Science:

• Virology
• Oncology
• Immunology

Background:

• Murine leukemia viruses (MuLVs) and murine sarcoma virus (MSV) interactions are complex.
• Neonatal MuLV infection can impact immune responses and cancer development.

Purpose of the Study:

• To elucidate in vivo interactions between MuLVs and MSV.
• To investigate the potentiation of MSV oncogenicity by MuLV infection.
• To explore genetic and immunologic factors influencing MSV oncogenesis.

Main Methods:

• Mice were infected neonatally with MuLV (Graffi or Gross) and later with MSV (Moloney strain).
• Immune reactivity was assessed using the hemolytic plaque-forming cell (PFC) technique.
• Endogenous MuLV-producing AKR mice were inoculated with MSV-M.
• MSV pseudotypes were identified using specific mouse antisera.

Main Results:

• Neonatal MuLV-Gi infection depressed immune reactivity (PFC).
• Co-infection with MuLV-Gi and MSV-M resulted in non-regressing sarcomas and leukemia.
• AKR mice showed delayed, non-regressing tumors after MSV-M inoculation, indicating resistance influenced by host factors.
• In vivo formation of new MSV pseudotypes was observed, with endogenous Gross virus acting as a helper.

Conclusions:

• MuLV infection can potentiate MSV oncogenicity, leading to more aggressive tumors.
• Genetic and immunologic factors play a significant role in MSV resistance.
• Endogenous retroviruses can act as helper viruses in MSV pseudotype formation.